Compare Eaton Corporation plc (ETN) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eaton Corporation plc vs TransMedics Group Inc — how do they compare? Eaton Corporation plc trades at $459.12 (market cap $172.82B), while TransMedics Group Inc trades at $87.58 (market cap $3.10B). The key difference: Eaton Corporation plc is far larger — about 55.7× TransMedics Group Inc's market cap, and Eaton Corporation plc pays a 0.99% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| ETN | TMDX | |
|---|---|---|
Market Cap | $172.82B | $3.10B |
Sector | Technology | Technology |
52-Week High | $459.29 | $150.42 |
52-Week Low | $315.82 | $61.99 |
Enterprise Value | $193.45B | $3.49B |
Dividend Yield | 0.99% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eaton Corporation (ETN) trades at $463.70, up 4.21% over the past 24 hours, near its 52-week high. The stock shows strong technical momentum with bullish moving averages and is approaching resistance at $467. Fundamentally, the company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of $3.15 beating estimates of $3.07, and raised its full-year 2026 outlook. Revenue growth is robust, supported by surging data-center demand and a $7 million U.S. Air Force contract for grid security announced on August 6, 2026.
The outlook remains positive given Eaton's exposure to AI-driven power infrastructure spending, but the stock's premium valuation (P/E of 45.31) poses a risk if growth moderates. Analyst consensus is strongly bullish with a $499.75 price target, though investors should monitor execution risks and macroeconomic pressures that could impact the industrial sector.
TransMedics Group (TMDX) trades at $87.42, down 1.12% on the day, with a bullish technical outlook from moving averages but bearish oscillators signaling potential overbought conditions. The company reported mixed Q2 2026 results, missing earnings estimates with EPS of $0.44 versus $0.50 expected, while revenue growth remains robust. Recent news highlights an ongoing investigation into fiduciary duties by directors, adding uncertainty.
The stock presents a cautious opportunity with strong analyst support (69% buy ratings) and a consensus price target of $99.57, implying upside, but risks include earnings volatility, margin pressures, and legal scrutiny. Fundamentals show solid profitability with a 22.69% net margin, though valuation multiples like P/E of 23.15 suggest premium pricing relative to historical norms.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
